New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Lonza Co-sponsors 21st Annual Southern California Industry Conference, Presents Technical Presentation for FiberAid(R) Prebiotic Fiber

Allendale, N.J. (March 31, 2008) – Lonza announces its participation in and co-sponsorship of the 21st annual Southern California Food Industry Conference (SCFIC) which took place on February 12, 2008 at Cal Poly Pomona University, Pomona, California. Bryan Rodriguez, technical marketing and scientific affairs manager for Lonza, presented the functional and physiological benefits of Lonza’s larch arabinogalactan-based prebiotic fiber, FiberAid®, as well as its compatibility for formulation into functional foods and beverages.

Rodriguez’s presentation explained the nutritional profile and various applications for FiberAid®, as well as its health and technological benefits. He brought attention to its function as a prebiotic fiber, high digestive tolerance, low viscosity, water solubility, stability at a wide range of temperatures and low pH, and its effectiveness in baking.

The 21st annual SCFIC converged together students, educators, industry executives and suppliers that participated in the theme “Ingredients for Thought.” The conference focused on emerging trends within the industry, including the proliferation of functional foods that enhance brain power, energy and immune health.

About Lonza

Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.

Lonza is headquartered in Basel, Switzerland, and is listed on the SWX Swiss Exchange. In 2007, Lonza had sales of CHF 2.87 billion. Further information can be found at


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.